Related Experiment Videos
Vitronectin receptor alpha(V)beta(3) integrin antagonists: chemical and structural requirements for activity and
Christophe Henry1, Nicolas Moitessier, Yves Chapleur
1Groupe SUCRES, Unité Mixte 7565 CNRS, Université Henri Poincaré-Nancy 1, BP 239, F-54506 Nancy-Vandoeuvre, France.
Mini Reviews in Medicinal Chemistry
|October 9, 2002
Summary
Alpha(V)beta(3) integrin antagonists are explored for cancer and osteoporosis drug potential. Structure-activity relationship studies reveal key chemical and structural requirements for effective drug candidates.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Alpha(V)beta(3) integrin is a cell surface receptor implicated in various physiological and pathological processes.
- Its role in cancer progression and bone remodeling makes it a significant drug target.
Purpose of the Study:
- To review the chemical and structural requirements of Alpha(V)beta(3) integrin antagonists.
- To identify potential drug candidates for cancer and osteoporosis.
Main Methods:
- Review of structure-activity relationship (SAR) studies.
- Analysis of chemical structures and biological activities of known antagonists.
Main Results:
- Deduced critical chemical and structural features necessary for Alpha(V)beta(3) integrin antagonism.
- Identified specific molecular characteristics contributing to antagonist activity and selectivity.
Conclusions:
- A tentative pharmacophore model for Alpha(V)beta(3) integrin antagonists has been proposed.
- Understanding these requirements can guide the design of novel therapeutic agents for cancer and osteoporosis.